Pediatrics, Rheumatology
About Dr. Pan
Dr. Pan specializes in the care and treatment of children with rheumatic diseases including juvenile idiopathic arthritis, juvenile dermatomyositis, childhood systemic lupus and vasculitides of childhood. Dr. Pan is the site Principal Investigator for the Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) and helps lead the quality improvement efforts in the Division of Pediatric Rheumatology at Hospital for Special Surgery. Dr. Pan is also a principal investigator in international clinical trials in juvenile idiopathic arthritis and has funding through the Childhood Arthritis and Rheumatology Research Alliance (CARRA).
Dr. Pan received her medical degree from New York University School of Medicine and completed her residency in Pediatrics at New York Presbyterian Hospital-Weill Cornell Medical Center. Dr. Pan then completed her fellowship in Pediatric Rheumatology at Hospital for Special Surgery. During her fellowship, Dr. Pan pursued clinical and translational research identifying biomarkers for flares in lupus as a part of the Mary Kirkland Center for Lupus Care. Dr. Pan is board-certified by the American Board of Pediatrics in Pediatrics and Pediatric Rheumatology.
Departments
Special Expertise
Childhood arthritis, childhood systemic lupus erythematosus, Vasculitis diseases of childhood, systemic sclerosis, juvenile dermatomyositis
Patient Stories
Videos
Insurance
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Assistant Attending Pediatrician, Hospital for Special Surgery
Assistant Professor of Pediatrics, Weill Cornell Medical College
Affiliations
American College of Rheumatology
American Academy of Pediatrics
American Academy of Pediatrics, Section on Rheumatology
Childhood Arthritis and Rheumatology Research Alliance (CARRA)
Arthritis Providers and Researchers Advocacy Alliance
Certification
American Board of Pediatrics
Pediatric Rheumatology
Education
MD, New York University School of Medicine, New York, NY
Internship
NewYork Presbyterian Hospital - Weill Cornell Medical Center, New York, NY
Residency
NewYork Presbyterian Hospital - Weill Cornell Medical Center, New York, NY
Fellowship
Hospital for Special Surgery, New Yok, NY
State Licensure
Languages
English, Mandarin Chinese
For My Patients
Publications by Dr. Pan
Selected Journal Articles
For all publications, please see the PubMed listing.
Selected Presentations
Walters H, Pan N, Moorthy LN, Ward, MJ, Peterson, M, Lehman TJ. Pediatric Systemic Lupus Erythematosus: Familial Inheritance, Severity, and Gender Comparisons. Pediatric Academic Societies Denver, CO 2011
Mertelsmann-Voss C, Kalliolias G.D, Pan N, Lehman TJ. A Novel Mutation in the TNFRSF1A gene identified in a 3 month old male with periodic fever heterozygous for the E148Q variant of MEFV gene. European League Against Rheumatism Annual European Congress of Rheumatology, London 2011
Jacek, Elzbieta E., Olferiev, Mikhail, Domingues, Vinicius, Duculan, Rolando, Pan, Nancy, Crow, Mary K., et al; Mucocutaneous Flares As Opposed to Flares From Other Organs Have the Strongest Association with High Type I Interferon Levels in Patents with Systemic Lupus Erythematosus. [abstract]. Arthritis Rheum 2011;63 Suppl 10 :1807.
Poster Presentation. American College of Rheumatology Annual Scientific Meeting. Chicago 2011
Pan, Nancy, Amigues, Isabelle, Duculan, Rolando, Aziz, Faiza, Lyman, Stephen L., Crow, Mary K., et al; Rapid Surges of Anti-dsDNA Titers Predict Severe Clinical Flares in Systemic Lupus Erythematosus. [abstract]. Arthritis Rheum 2011;63 Suppl 10 :1709.
ORAL PRESENTATION American College of Rheumatology Annual Scientific Meeting. Chicago 2011
Research
Research Interests
Juvenile idiopathic arthritis, systemic lupus erythematosus
Industry Relationships
Industry Relationships
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of March 24, 2023, Dr. Pan reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.